Rep. Debbie Dingell

Maddy summaryThis bill would protect unaccompanied children by repealing fee requirements and other provisions in the "One Big Beautiful Bill Act" that have created barriers to their access to humanitarian protections. It specifically exempts unaccompanied children from paying fees for asylum applications, employment authorization, and immigration court proceedings, and requires the government to refund fees already paid under the repealed provisions. The bill also repeals provisions allowing for summary removal of children without due process, intrusive body examinations without safeguards, and sharing of sponsor information with immigration enforcement that has led to family separations. These changes would directly affect unaccompanied children seeking asylum or other protections in the United States, ensuring they can access legal processes without financial barriers or heightened risks of exploitation. The bill aims to uphold protections for unaccompanied children established under the William Wilberforce Trafficking Victims Protection Reauthorization Act of 2008 (TVPRA).

Maddy summaryThis bill amends the SUPPORT for Patients and Communities Act to expand substance abuse and suicide prevention services for children, adolescents, and young adults (up to age 25). It requires eligible providers - like pediatric specialists, emergency departments, and children’s hospitals - to offer parents or guardians counseling on preventing overdose/suicide and provide supplies to reduce access to lethal means (e.g., safe storage containers). The bill allocates at least $2 million annually in grants to fund these prevention programs through eligible entities, with funding authorized for fiscal years 2026-2030. It directly affects young people at risk of substance misuse or self-harm and their caregivers.

Maddy summaryHR 6358, the Veteran Education Empowerment Act, creates a federal grant program to help colleges establish or improve dedicated Student Veteran Centers. These centers provide veterans, active-duty service members, and their families with lounge space, benefits counseling, academic support, and mental health services. Institutions must serve significant numbers of veterans and have sustainability plans to qualify for grants, with funding capped at $500,000 per institution over four years. The bill directly affects colleges serving veterans and aims to address challenges like isolation and transition difficulties through centralized campus support.

Give Kids a Chance Act of 2025 This bill expands the Food and Drug Administration’s (FDA’s) authority with respect to research on rare pediatric diseases, including by permitting the FDA to take enforcement action against drug sponsors that fail to satisfy pediatric study requirements and by reauthorizing programs that support pediatric research.  Specifically, the bill modifies requirements relating to molecularly targeted pediatric cancer investigations to permit research on new drugs in combination with active ingredients that have already been approved, provided certain conditions are met; permits the FDA to take enforcement action against drug sponsors that fail to comply with pediatric study requirements, if such sponsors demonstrated a lack of due diligence in satisfying the requirement; renews the FDA’s authority to award priority review vouchers to sponsors of new products intended to treat rare pediatric diseases through September 30, 2029; and reauthorizes through FY2027 certain funding for the National Institutes of Health to support priority pediatric research.  The bill also provides statutory authority for the FDA’s interpretation of the orphan drug exclusivity period. The bill specifies, consistent with FDA regulations, that the seven-year market exclusivity period for drugs for rare diseases or conditions (i.e., orphan drugs) prohibits the approval of the same drug for the same approved use or indication with respect to the disease or condition. (In Catalyst Pharmaceuticals, Inc. v. Becerra , a court rejected the FDA’s interpretation and held that orphan drug exclusivity extends to all uses or indications for the disease or condition.)

Maddy summaryHRES 917 is a ceremonial resolution congratulating Korson’s Tree Farms in Montcalm County, Michigan, for being selected to provide the 2025 White House Christmas tree. It recognizes the farm as the first Michigan grower in 41 years to supply the official White House tree and highlights Michigan’s Christmas tree industry, which ranks third nationally in harvests and generates over $40 million annually. The resolution includes no policy changes or funding; it solely offers congratulations, acknowledges the farm’s past contest wins, and invites the farm to the Capitol for recognition. This procedural resolution affects no legislation or regulations, serving only as a symbolic honor.

Maddy summaryThe Advancing Access to Telehealth Act makes permanent Medicare's temporary telehealth flexibilities that were expanded during the public health emergency. It allows Medicare beneficiaries to receive telehealth services for mental health, stroke care, substance use disorder, and home dialysis without needing an initial in-person visit. The bill also expands eligibility for telehealth providers to include more healthcare professionals and permanently authorizes Federally Qualified Health Centers and Rural Health Clinics to offer telehealth services. Additionally, it permits audio-only telehealth calls for certain services, removing previous video-only requirements.

Maddy summaryHRES 906 would change House rules to require a 60% vote of members present and voting to censure, disapprove, or remove any House member, delegate, or resident commissioner from committee assignments. Currently, a simple majority (50%+1) could trigger these actions, but this bill raises the threshold to a supermajority. The change applies directly to all voting members of the House and affects disciplinary procedures for members. This is a procedural rule change that makes it harder to take formal disciplinary actions against House members.

Maddy summaryThis bill expands Medicare's drug price negotiation program to cover 50 drugs (up from 20) and requires health insurers to apply negotiated prices to cost-sharing for beneficiaries. It establishes annual out-of-pocket cost-sharing limits for prescription drugs under group health plans and insurance coverage, with specific limits of $2,000 for self-only coverage in 2027 that will increase annually. The bill also sets specific cost-sharing limits for insulin products, requiring coverage with no deductible and cost-sharing of no more than $35 per 30-day supply or 25% of the negotiated price. These provisions affect Medicare beneficiaries, people with group health plans, and health insurers across the country. The bill applies to plan years beginning on or after January 1, 2027.

Maddy summaryHR 6212, the Good Samaritan Menstrual Products Act, protects donors and nonprofits from liability when providing menstrual products in good faith. It shields people, manufacturers, distributors, and nonprofits from civil or criminal liability for the condition of "apparently usable" donated products (those meeting all safety standards but not necessarily marketable). The law applies to products like tampons, cups, and liners distributed to individuals in need through nonprofits. Liability protection does not apply if gross negligence or intentional misconduct causes injury or death.

Maddy summaryThe HEAR Act of 2025 adds Medicare coverage for hearing rehabilitation services and hearing aids. It directly affects Medicare beneficiaries with hearing loss who need new devices or services, requiring a comprehensive assessment and meeting specific criteria (like not having received hearing aids in the past three years). Key provisions include defining "hearing rehabilitation" to cover audiologist assessments, counseling, and device fitting, and specifying that covered hearing aids must meet FDA standards (excluding over-the-counter models). The bill also removes previous exclusions that blocked this coverage. These changes apply to services provided after a date set by the Health and Human Services Secretary, starting no earlier than January 1, 2026.